586963-15-7

Upstream product

• 40615-36-9 4,4'-dimethoxytrityl chloride 
• 586963-14-6 1-[3-(2-deoxy-β-D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]-purin-7-yl]-1-hexyl-2-methylpropanoate 
• 42134-50-9 2,3-epoxyoctanal 
• 586963-13-5 1-(3',5'-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-[3-(2-deoxy-β-D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]-purin-7-yl])-1-hexyl-2-methylpropanoate 
• 586963-12-4 1-(3',5'-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-[3-(2-deoxy-β-D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]-purin-7-yl])-1-hexanol 
• 276681-46-0 1-[3-(2-deoxy-β-D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]purin-7-yl]-1-hexanol 
• 2548-87-0 (E)-2-Octenal 

Relevant academic research and scientific papers

Site-specific incorporation of the 1-hexanol-1,N6-etheno-2′-deoxyadenosine adduct into oligodeoxyribonucleotides

Modified oligonucleotides that contain the hydrophobic 1-hexanol-1,N6-etheno-2′-deoxyadenosine adduct have been synthesized using a mild solid phase phosphoramidite chemistry. The presence and the integrity of the modified nucleoside in the syn